Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-061201
Filing Date
2012-11-13
Accepted
2012-11-13 09:20:03
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v325978_10q.htm 10-Q 592877
2 EX-31.1 v325978_ex31-1.htm EX-31.1 6959
3 EX-31.2 v325978_ex31-2.htm EX-31.2 6942
4 EX-32.1 v325978_ex32-1.htm EX-32.1 3049
5 EX-32.2 v325978_ex32-2.htm EX-32.2 3038
  Complete submission text file 0001144204-12-061201.txt   6188996

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcli-20120930.xml EX-101.INS 856134
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20120930.xsd EX-101.SCH 73846
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20120930_cal.xml EX-101.CAL 27440
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20120930_def.xml EX-101.DEF 238770
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20120930_lab.xml EX-101.LAB 428135
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20120930_pre.xml EX-101.PRE 271774
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

EIN.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54365 | Film No.: 121196175
SIC: 2836 Biological Products, (No Diagnostic Substances)